Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Clin Neurophysiol. 2013 Mar 20;124(7):1290–1296. doi: 10.1016/j.clinph.2013.02.007

Table 1.

Patient Profile.

Number of sampled sites
Patient number Age at surgery Antiepileptic medications Seizure onset zone Sampled hemisphere Medial- occipital region Ventral- temporal region Dorsal- occipital region
1 14 LEV, OXC, LCM Not available* Left 6 4 6
2 14 OXC, PHT Right Temporal Right 2 2 4
3 8 CBZ, LCM Right Frontal Right 4 2 4
4 10 OXC, VPA, LCM Right Parietal Right 5 3 5
5 9 LEV, OXC Left Parietal Left 6 3 3
6 12 OXC, LEV, VPA Left Temporal Left 2 4 3
7 3 LEV, LMG Left Parietal & Frontal Left 6 5 4
8 9 LMG, TPM Left Temporal Left 5 6 4
9 17 LCM, LEV Right Temporal Right 4 4 7
10 15 LMG, ZNS, LEV Right Temporal Right 2 5 2
*

Lesionectomy (left parietal lesion) was performed. CBZ: carbamazepine, LCM: lacosamide, LEV: levetiracetam, LMG: lamotrigine, OXC: oxcarbazepine, PHT: phenytoin, VPA: valproate, TPM: topiramate, ZNS: zonisamide.